Profile
NAYA ABT BSX-PA SYK MDT BSX
Company Name NAYA Biosciences, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.47M $194.01B $175.45B $139.91B $129.39B $109.92B
Employees 0.03K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Steven M. Shum Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
NAYA ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
NAYA ABT BSX-PA SYK MDT BSX
Last Close $2.2 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $2.74 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $0.2 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -19.71 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 1000 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
NAYA ABT BSX-PA SYK MDT BSX
1 Month Return 0 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 0 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 0 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 503.07 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return 171.6 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return 169.61 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NAYA ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.15 % - 0.93 % 2.81 % -
Dividend Paid and Capex Coverage Ration (TTM) -51.36 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
NAYA ABT BSX-PA SYK MDT BSX
Asset Growth 151 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth 164.63 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth 116.25 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year 978.67 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year 1284.25 % 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year 144965.15 % 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth -13.86 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth -13.21 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share -838.95 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share -1216.33 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share -376.13 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth -20.07 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) 37.45 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG -238.87 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG -780.78 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG -4992.5 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth -488.41 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth -488.41 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share 14349.8 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share 1097.88 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share 1176.76 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share 980.8 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth 57.03 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth 39.26 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
NAYA ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 37.12 % 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -71.38 % 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -423.26 % 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -171.85 % 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 99.89 % 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 101.34 % 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -470.61 % 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -54.36 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 27.4 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 0.62 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM 13.82 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 177.88 % 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 14.98 % 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -15.52 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -15.82 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 271.5 % 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -101 % 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.95 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -54.36 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.3 28.05 29.17 32.67 24.85 29.12
Price To Operating Cash Flows Ratio TTM -0.14 21.36 23.8 27.74 18.18 23.76
Price Cash Flow Ratio TTM -0.14 21.36 23.8 27.74 18.18 23.76
Income Statement (TTM)
NAYA ABT BSX-PA SYK MDT BSX
Revenue $0.01B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 44% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -30.19 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
NAYA ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.03B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0.01B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.05B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
NAYA ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.18
ADGM Adagio Medical Holdings, Inc. 1.0162
AEMD Aethlon Medical, Inc. 1.93
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.065
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 185.225
ALUR Allurion Technologies Inc. 1.06
AMIX Autonomix Medical, Inc. Common Stock 0.388
ANIK Anika Therapeutics, Inc. 9.9668
AORT Artivion, Inc. 36.98
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.775
ARAY Accuray Incorporated 0.559
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.32
AVNS Avanos Medical, Inc. 14.92
AVR Anteris Technologies Global Corp. Common Stock 5.52
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to NAYA
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 214.255
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 162.32
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 162.33
VEMPX Vanguard Extended Market Index InstlPlus 0 400.57
Unlock